Interpace Biosciences, Inc. ( IDXG) - Stock Earnings
IDXG Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q4 | -1.6 million USD | 8.3 million USD |
| 2023Q1 | 351000 USD | 9.8 million USD |
| 2023Q2 | 175000 USD | 11.0 million USD |
IDXG Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2020 | -26.5 million USD | 32.4 million USD |
| 2021 | -14.9 million USD | 41.3 million USD |
| 2022 | -22.0 million USD | 31.8 million USD |
| 2025 Est. | — | — |
IDXG
Price: $1.49
52 week price:
Earnings Per Share: -0.66 USD
P/E Ratio: -2.70
Exchange: OQX
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 1193
Ebitda: -2.5 millionMarket Capitalization: 45.2 million